International law firm CMS is pleased to announce that Borys Danevych will be joining the firm as a partner and Head of Life Sciences at CMS Cameron McKenna Nabarro Olswang in Kyiv from 1 November 2020. Borys was previously the owner and head of Danevych.Law, a leading life sciences boutique law firm in Ukraine, which will be strategically integrated into CMS Cameron McKenna Nabarro Olswang in Kyiv following his appointment.

As part of this integration, CMS is also pleased to welcome Borys’ legal and administrative team to the firm, including Anastasiya Filipiuk, Senior Associate, Artem Grudinin, Associate, Anastasiya Maistruk, Associate, and Iryna Tvardovska, Administrative Executive, all of whom are joining from Danevych.Law. Both Borys and his team will be based in Kyiv and will join the firm’s existing Commercial team, where they will continue to offer leading life sciences advice.

   Anastasiya Filipiuk,               Artem Grudinin,                       Anastasiya Maistruk,

    Senior Associate                    Associate                                     Associate

As a leading life sciences lawyer in Ukraine, Borys is widely recognised for his work in the sector. He is ranked in Chambers Europe as a leading IBorys brings more than 15 years of experience working with international pharmaceutical, biotech, research and development, and medical devices companies, as well as healthcare services and health technology organisations. He regularly advises clients on regulatory, anti-counterfeiting, compliance in life sciences, pharmaceutical competition and IP, policy dialogue projects and regulatory disputes. Borys also counsels clients on employment and personal data protection issues, investor-state disputes, and white-collar criminal investigations.P practitioner, with a focus on life sciences and pharmaceuticals, and enjoys further mentions in Legal 500 for his white-collar, competition and IP advice, as well as life-sciences-related dispute resolution.

Graham Conlon, Managing Partner of CMS Cameron McKenna Nabarro Olswang in Kyiv, comments: “We are delighted to announce this strategic integration and to welcome Borys and his team to the firm. With life sciences increasingly attracting the global spotlight, this important expansion of the team demonstrates our ongoing commitment to delivering best-in-class advice for our clients. The breadth and depth of Borys’ experience, along with the expert support of his committed team, will strengthen and expand our life sciences offering.”

Borys Danevych adds: “CMS has a very impressive global life sciences group and I see many opportunities to further develop our capabilities for clients in areas such as biotech, brand protection and health tech. I also see significant additional value in terms of being able to offer strong transactional, IP, dispute resolution, TMT and tax capability to our clients going forward. I am excited to join the firm – as are my colleagues from my previous firm. We look forward to working with the team both in Ukraine and across Europe.”

CMS has more than 300 life sciences specialists operating globally. The firm is ranked for life sciences in Chambers & Partners Europe and Legal 500 with clients commenting that

CMS is “an undisputed go-to-firm” with a “visible and highly respected” life sciences group.